Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

4.92
+0.07001.44%
Post-market: 4.92-0.00010.00%17:42 EST
Volume:852.39K
Turnover:4.16M
Market Cap:266.62M
PE:3.82
High:4.93
Open:4.88
Low:4.81
Close:4.85
52wk High:7.54
52wk Low:3.93
Shares:54.19M
Float Shares:38.26M
Volume Ratio:0.70
T/O Rate:2.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.29
EPS(LYR):-1.5527
ROE:75.90%
ROA:-29.57%
PB:1.56
PE(LYR):-3.17

Loading ...

Abeona Therapeutics announces employee inducement grants

TIPRANKS
·
Oct 01

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 01

Euronext: Quarterly Review Of CAC Family

Reuters
·
Sep 12

Abeona Therapeutics Inc - Grants Equity Awards to New Non-Executive Employees

THOMSON REUTERS
·
Sep 02

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 02

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
Aug 29

Abeona Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 18

Eric Crombez, Director, Reports Disposal of Common Shares in Abeona Therapeutics Inc

Reuters
·
Aug 16

CFO Joseph Walter Vazzano Reports Disposal of Abeona Therapeutics Inc. Common Shares

Reuters
·
Aug 16

Oppenheimer Adjusts Abeona Therapeutics Price Target to $20 From $19, Maintains Outperform Rating

MT Newswires Live
·
Aug 15

Abeona Therapeutics, Inc. : Oppenheimer Raises Target Price to $20 From $19

THOMSON REUTERS
·
Aug 15

Abeona Therapeutics Shares Rise on Higher 2Q Net, Drug Launch

Dow Jones
·
Aug 15

Abeona Therapeutics Q2 net income beats estimates on PRV sale, sees profitability in H1 2026

Reuters
·
Aug 14

Abeona Therapeutics Q2 EPS $1.71 Beats $(0.39) Estimate

Benzinga
·
Aug 14

Abeona Therapeutics Q2 Income From Operations USD -22.792 Million VS. Ibes Estimate USD -19.3 Million

THOMSON REUTERS
·
Aug 14

Abeona Therapeutics Inc: U.S. Launch on Track and First Zevaskyn Patient Treatment Expected in 3Q 2025

THOMSON REUTERS
·
Aug 14

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

GlobeNewswire
·
Aug 14

Abeona Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Aug 09

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 01